Analyst expectations ^ (https://www.marketscreener.com/quote/stock/NANOSONICS-LIMITED-6499689/finances/)
Some projected numbers. Valuation is just a simple (NPAT x Multiple) + Cash, Nanosonics has no long term debt.
I'd expect Coris to contribute from FY26, wouldn't be a hard sell given hospitals are already cleaning endoscopes manually, if this is a superior method it's a no brainer from a risk mitigation perspective (And time / cost saving I'd imagine).If anyone has a view of the multiple NAN could sit at in 3 years time it would be much appreciated, I have been quite conservative also knowing Nanosonics fully expenses R&D.Obviously NAN will deserve a higher multiple if Coris is approved as it de-risks the business from 1 product to 2. I like the Printer & Ink style business model and deserves a premium over the market. Interested if anyone has a view around NAN conducting a share buy-back to deploy some of the spare cash (Assuming they aren't preparing for an acquisition).
From my rough numbers at the current price it's a decent risk/reward profile.
- Forums
- ASX - By Stock
- Ann: H2 FY24 Trading Update
Analyst expectations ^...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.31 |
Change
-0.020(0.60%) |
Mkt cap ! $1.004B |
Open | High | Low | Value | Volume |
$3.30 | $3.38 | $3.26 | $1.578M | 472.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2130 | $3.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.34 | 2542 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2130 | 3.290 |
4 | 14998 | 3.280 |
2 | 3412 | 3.270 |
1 | 412 | 3.260 |
4 | 3812 | 3.250 |
Price($) | Vol. | No. |
---|---|---|
3.340 | 2542 | 2 |
3.350 | 412 | 1 |
3.360 | 412 | 1 |
3.370 | 707 | 2 |
3.380 | 4822 | 3 |
Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
Featured News
NAN (ASX) Chart |